News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,024 Results
Type
Article (39150)
Company Profile (284)
Press Release (648590)
Section
Business (203905)
Career Advice (1996)
Deals (35372)
Drug Delivery (89)
Drug Development (80852)
Employer Resources (168)
FDA (16099)
Job Trends (14808)
News (344648)
Policy (32450)
Tag
Academia (2530)
Alliances (49188)
Alzheimer's disease (1262)
Approvals (16060)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11582)
Biotechnology (200)
Breast cancer (189)
Cancer (1375)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64707)
Collaboration (485)
Compensation (262)
COVID-19 (2541)
C-suite (109)
Data (1391)
Diabetes (176)
Diagnostics (6170)
Earnings (84895)
Employer resources (146)
Events (110014)
Executive appointments (397)
FDA (16785)
Funding (431)
Gene therapy (195)
GLP-1 (599)
Government (4333)
Healthcare (18697)
Infectious disease (2634)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16344)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7862)
Lung cancer (198)
Manufacturing (208)
Medical device (13213)
Medtech (13218)
Mergers & acquisitions (19195)
Metabolic disorders (460)
Neuroscience (1583)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1700)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (120)
People (56462)
Phase I (20127)
Phase II (28498)
Phase III (21240)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (238)
Rare diseases (264)
Real estate (5892)
Regulatory (21679)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1468)
Startups (3562)
United States (15236)
Vaccines (564)
Weight loss (182)
Date
Today (126)
Last 7 days (587)
Last 30 days (2374)
Last 365 days (35289)
2024 (35130)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37275)
Australia (6087)
California (3830)
Canada (1457)
China (307)
Colorado (172)
Connecticut (178)
Europe (79833)
Florida (537)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (634)
Massachusetts (2973)
Michigan (175)
Minnesota (291)
New Jersey (1108)
New York (1091)
North Carolina (743)
Northern California (1700)
Ohio (146)
Pennsylvania (928)
South America (1092)
Southern California (1468)
Texas (554)
Utah (109)
Washington State (401)
688,024 Results for "pharmalogical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Life Molecular Imaging and PharmaLogic announce Neuraceq® availability in Cincinnati, OH
October 30, 2024
·
5 min read
BioMidwest
Ratio Announces Expansion of Manufacturing Agreement with PharmaLogic for FAP-Targeted Radiopharmaceuticals
Ratio Therapeutics Inc. announced an expanded manufacturing agreement with PharmaLogic, a world-class contract development and manufacturing organization specializing in radiopharmaceutical production and distribution.
March 12, 2024
·
3 min read
Business
PharmaLogic announces opening of radiopharmaceutical production facility in New York City
PharmaLogic Holdings Corp., a world-class contract development and manufacturing organization and radiopharmacy solutions provider, celebrates the opening of its radiopharmaceutical production and research facility in the Bronx, New York.
May 13, 2024
·
2 min read
Business
PharmaLogic announces opening of new state-of-the-art radiopharmaceutical production facility in Cincinnati
PharmaLogic Holdings Corp. announced the opening of its new radiopharmaceutical production and research facility in Cincinnati, Ohio.
April 22, 2024
·
2 min read
BioMidwest
Meilleur Technologies Inc. Announces Execution of Manufacturing Agreement with PharmaLogic for Production of the Next-Generation Amyloid PET Imaging Biomarker, NAV4694
Meilleur Technologies Inc. announced it has signed an agreement with PharmaLogic Holdings Corporation granting PharmaLogic the rights to manufacture fluorine-18 [F18]NAV4694, a next-generation investigational imaging biomarker used in Positron Emission Tomography imaging studies to assess the status of amyloid plaque in the brain.
December 20, 2023
·
2 min read
Press Releases
Life Molecular Imaging and PharmaLogic announce Neuraceq® availability in Denver
August 21, 2024
·
5 min read
Press Releases
PharmaLogic announces opening of new state-of-the-art radiopharmaceutical production facility in Salt Lake City
October 20, 2024
·
2 min read
Deals
Nusano and PharmaLogic Announce Strategic Supply Agreement to Enable Current and Emerging Radiopharmaceuticals
July 10, 2024
·
3 min read
BioMidwest
Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225
Eckert & Ziegler and PharmaLogic Holdings Corp. have signed a reservation agreement for the supply of the therapeutic radioisotope Actinium-225.
October 10, 2023
·
2 min read
Business
ARTBIO and PharmaLogic Announce Supply Agreement for Lead-212 based Therapeutic Candidate AB001 for New York and Surrounding States
PharmaLogic Holdings Corp. and ARTBIO today announce a manufacturing and supply agreement for ARTBIO’s lead-212 (212Pb) based radiopharmaceutical candidate, AB001, for the treatment of prostate cancer.
January 12, 2024
·
3 min read
1 of 68,803
Next
